This inventor holds 1 USPTO granted patent. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Stephen W. Laws
Introduction
Stephen W. Laws is an accomplished inventor based in Dorchester, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of alpha-1 antitrypsin deficiency (AATD). His innovative work has the potential to impact many lives.
Latest Patents
Stephen W. Laws holds a patent for "Processes for preparing modulators of alpha-1 antitrypsin." This patent outlines large-scale processes for preparing a modulator of alpha-1 antitrypsin (AAT) activity. The modulator may be useful for treating AATD and includes compounds such as 4-(5-(4-fluorophenyl)-6-(tetrahydro-2H-pyran-4-yl)-1,5-dihydropyrrolo[2,3-f]indazol-7-yl)benzoic acid (Compound 1) and 3-[5-(4-fluorophenyl)-6-isopropyl-1H-pyrrolo[2,3-f]indazol-7-yl]propanoic acid (Compound 2), along with pharmaceutically acceptable salts of these compounds. He has 1 patent to his name.
Career Highlights
Stephen is currently employed at Vertex Pharmaceuticals, Inc., where he continues to develop innovative solutions in the pharmaceutical industry. His work focuses on enhancing the understanding and treatment of genetic disorders, particularly those related to protein deficiencies.
Collaborations
Stephen has collaborated with notable colleagues such as Adam R. Looker and Stefanie Roeper. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Stephen W. Laws is a prominent figure in the field of pharmaceutical innovation, with a focus on addressing critical health issues. His contributions through patents and collaborations highlight his commitment to improving patient outcomes.